The CAR-TCR Summit is dedicated to advancing the future of cell therapy through next generation innovation.
Fenwick's Life Sciences Industry Co-Lead, Stefano Quintini will be speaking at the 7th CAR-TCR Summit Europe. Stefano will participate in a new panel for 2024, titled "Investor & Biopharma Partnerships Evening." The discussion will highlight perspectives from the pharmaceutical industry and investors on the current market dynamics, as well as opportunities to initiate dialogue on strategies to recover investments and protect clinical development processes for cell therapies.